ArticleOncotarget2017

Molecularly targeted co-delivery of a histone deacetylase inhibitor and paclitaxel by lipid-protein hybrid nanoparticles for synergistic combinational chemotherapy.

Hima Bindu Ruttala et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.